Latest OSI Pharmaceuticals Stories
By Lisa Richwine WASHINGTON (Reuters) - A Genentech Inc. drug that reversed vision loss in some patients won U.S. approval on Friday for treating the leading cause of blindness in the elderly.
WASHINGTON (Reuters) - Pfizer Inc. and OSI Pharmaceuticals Inc. have reported rare cases of serious allergic reactions with use of their eye drug Macugen along with other medications, the U.S. Food and Drug Administration said on Friday.
CHICAGO (Reuters) - Genentech Inc. said on Tuesday early results from a mid-stage trial show that combining lung cancer drug Tarceva with Avastin works no better than Avastin alone in patients with advanced kidney cancer, sending shares of Tarceva partner OSI Pharmaceuticals Inc. down 7 percent.
- An armed gangster.